The Global Tick-borne Encephalitis Inactivated Vaccine Market was valued at USD 562.57 Million in 2023 and is projected to reach USD 807.09 Million by 2029, growing at a Compound Annual Growth Rate (CAGR) of 6.20% during the forecast period (2024–2029). This sustained growth is driven by the expanding geographical range of TBE-carrying ticks due to climate change, increased public health awareness, rising travel and tourism in endemic regions, and supportive government vaccination programs.

As the threat from tick-borne diseases intensifies globally, the development and distribution of safe and effective vaccines are paramount. In this blog, we profile the Top 10 Companies in the Tick-borne Encephalitis Inactivated Vaccine Industry—a group of pharmaceutical innovators, vaccine specialists, and public health partners dedicated to protecting populations from this serious neurological infection.

Download FREE Sample Report:
Global Tick-borne Encephalitis Inactivated Vaccine Market – View in Detailed Research Report

---

🔟 1. Pfizer Inc.

Headquarters: New York City, New York, USA
Key Offering: TicoVac (FSME-IMMUN)

Pfizer is a global pharmaceutical giant with a strong portfolio of vaccines, including TicoVac, marketed as FSME-IMMUN outside the US. This vaccine is a cornerstone of TBE prevention in many endemic countries. Pfizer’s extensive global distribution network ensures wide accessibility to this critical prophylactic.

Research & Development Initiatives:

• Continuous clinical studies to confirm vaccine efficacy and safety profiles

• Investment in next-generation vaccine platform technologies

• Public health collaborations to expand vaccination coverage in high-risk areas

---

9️⃣ 2. Baxter AG (now part of Pfizer)

Headquarters: Vienna, Austria (Historical Origin)
Key Offering: FSME-IMMUN (legacy product lineage)

The original developer of the FSME-IMMUN vaccine, Baxter’s vaccine business was acquired by Pfizer, significantly bolstering Pfizer’s standing in the TBE vaccine market. The knowledge and manufacturing expertise from Baxter form the historical backbone of one of the most widely used TBE vaccines globally.

Research & Development Initiatives:

• Pioneered the inactivated virus technology for TBE prevention

• Established the standard vaccination schedules still in use today

Download FREE Sample Report:
Global Tick-borne Encephalitis Inactivated Vaccine Market – View in Detailed Research Report

---

8️⃣ 3. Valneva SE

Headquarters: Saint-Herblain, France
Key Offering: TBE vaccine

Valneva is a specialty vaccine company focused on providing protection against infectious diseases with limited vaccination options. Their TBE vaccine is a key product, particularly for travelers and residents in endemic zones across Europe. Valneva is known for its targeted approach to vaccine development and distribution.

Research & Development Initiatives:

• Focus on enhancing vaccine stability and storage requirements

• Development of combination vaccines to address multiple public health threats

---

7️⃣ 4. Pfizer Consumer Healthcare (Formerly Encephalitis Global)

Headquarters: New York, USA (via Pfizer structure)
Key Offering: Consumer awareness and education platforms

While not a direct manufacturer, entities focused on encephalitis awareness, often under the umbrella of large pharmaceutical consumer health divisions, play a critical role. They drive vaccination uptake through public education campaigns about the risks of TBE and the importance of prophylaxis, indirectly supporting market growth for manufacturers like Pfizer.

Research & Development Initiatives:

• Development of digital health tools for vaccination reminders and education

• Collaborative research on vaccination behavior and hesitancy

---

6️⃣ 5. Microgen

Headquarters: Moscow, Russia
Key Offering: Tick-E-Vac, EnceVir

Microgen is a leading Russian biological products company and a major supplier of TBE vaccines within Russia and the Commonwealth of Independent States (CIS). Their vaccines, such as Tick-E-Vac and EnceVir, are critical for national immunization programs in highly endemic regions like Siberia and the Russian Far East.

Research & Development Initiatives:

• Development of vaccines tailored to local TBE virus subtypes

• Focus on cost-effective production for broad public health implementation

---

5️⃣ 6. Beijing Tiantan Biological Products Co., Ltd.

Headquarters: Beijing, China
Key Offering: Inactivated TBE Vaccine

As a subsidiary of China National Biotec Group (CNBG), Beijing Tiantan is a key player in the Chinese vaccine market. They produce an inactivated TBE vaccine that is essential for protecting populations in forested regions of northern China where TBE is prevalent.

Research & Development Initiatives:

• Alignment with Chinese national disease prevention strategies

• Investment in advanced cell culture technologies for vaccine production

Read Full Report:
Global Tick-borne Encephalitis Inactivated Vaccine Market – View in Detailed Research Report

---

4️⃣ 7. Lanzhou Institute of Biological Products Co., Ltd.

Headquarters: Lanzhou, China
Key Offering: Inactivated TBE Vaccine

Another major Chinese vaccine manufacturer under CNBG, the Lanzhou Institute contributes significantly to the domestic supply of TBE vaccines. Their role is crucial for maintaining public health defenses in endemic areas and ensures vaccine security within the country.

Research & Development Initiatives:

• Process optimization for large-scale vaccine manufacturing

• Research on improving vaccine immunogenicity for different age groups

---

3️⃣ 8. Public Health England (UK Health Security Agency)

Headquarters: London, United Kingdom
Key Offering: Policy guidance, immunization schedules

While not a commercial manufacturer, national public health bodies like the UK Health Security Agency (successor to PHE) are critical market influencers. They issue vaccination recommendations for travelers and assessors of vaccine safety and efficacy, directly impacting vaccine adoption and guiding healthcare providers.

Research & Development Initiatives:

• Epidemiological surveillance of TBE cases and tick distribution

• Cost-effectiveness analyses to inform national immunization policy

---

2️⃣ 9. Superdrug Health Clinic

Headquarters: London, United Kingdom
Key Offering: Travel vaccination services including TBE

As a major provider of travel health services in the UK, Superdrug Health Clinic plays a vital role in the market’s distribution chain. They make the TBE vaccine accessible to the public, particularly travelers visiting endemic areas in Europe and Asia, driving market volume through retail health services.

Research & Development Initiatives:

• Development of streamlined patient journey for travel vaccinations

• Integration of digital health passports and vaccination records

---

1️⃣ 10. Sonic HealthPlus

Headquarters: Melbourne, Australia
Key Offering: Corporate and travel health services, including TBE vaccination

Sonic HealthPlus is a leading provider of occupational and travel health services in the Asia-Pacific region. They are a key endpoint for vaccine administration, ensuring that individuals requiring protection against TBE, especially corporate travelers and expatriates, have access to vaccination through their extensive clinic network.

Research & Development Initiatives:

• Focus on corporate health programs and risk assessment for businesses with overseas operations

• Implementation of efficient vaccine management systems

Read Full Report:
Global Tick-borne Encephalitis Inactivated Vaccine Market – View in Detailed Research Report

---

🌍 Outlook: The Future of TBE Prevention is Proactive and Precision-Based

The Tick-borne Encephalitis Inactivated Vaccine market is evolving from a niche travel vaccine to an essential public health tool in expanding endemic regions. The industry is shifting towards broader vaccination programs, improved vaccine formulations, and integrated tick-borne disease management strategies.

📈 Key Trends Shaping the Market:

• Expansion of national immunization programs in Central and Eastern Europe

• Increased demand from travelers and outdoor workers as tick habitats grow

• Research into next-generation vaccines with longer duration of protection and fewer doses

• Growing integration of TBE vaccination into comprehensive travel health packages

Read Full Report:
Global Tick-borne Encephalitis Inactivated Vaccine Market – View in Detailed Research Report

The companies listed above are not only supplying a critical vaccine—they are building a global defense network against a rising infectious disease threat.